To include your compound in the COVID-19 Resource Center, submit it here.
Valeant will acquire Lithuanian branded generics company Sanitas for about €314 million ($440.2 million) in cash. Valeant
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury